未登录

S

Sushmita Sarker

University of Calcutta

H指数:8

被引数:323

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Systemic Codelivery of Thymoquinone and Doxorubicin by Targeted Mesoporous Silica Nanoparticle Sensitizes Doxorubicin-Resistant Breast Cancer by Interfering between the MDR1/P-gp and miR 298 Crosstalk

靶向介孔二氧化硅纳米颗粒对百里香醌和阿霉素的全身共递送通过干扰MDR1/p-gp和miR 298串扰使阿霉素耐药的乳腺癌敏感

ACS BIOMATERIALS SCIENCE & ENGINEERING

IF5.5

2024-09-171

PRE

microRNA-205 represses breast cancer metastasis by perturbing the rab coupling protein [RCP]-mediated integrin β1 recycling on the membrane

IF8.1

2023-11-090

PRE

Delivery of novel coumarin-dihydropyrimidinone conjugates through mixed polymeric nanoparticles to potentiate therapeutic efficacy against triple-negative breast cancer

BIOMATERIALS SCIENCE

IF5.7

2021-01-014

PRE

Delivery of gefitinib in synergism with thymoquinone via transferrin-conjugated nanoparticle sensitizes gefitinib-resistant non-small cell lung carcinoma to control metastasis and stemness

BIOMATERIALS SCIENCE

IF5.7

2021-01-0111

PRE

Delivery of dual miRNA through CD44-targeted mesoporous silica nanoparticles for enhanced and effective triple-negative breast cancer therapy

Biomaterials Science

IF5.7

2020-01-0169

PREAI

Transferrin-decorated thymoquinone-loaded PEG-PLGA nanoparticles exhibit anticarcinogenic effect in non-small cell lung carcinoma via the modulation of miR-34a and miR-16

BIOMATERIALS SCIENCE

IF5.7

2019-01-0159

PREAI

Methylglyoxal at metronomic doses sensitizes breast cancer cells to doxorubicin and cisplatin causing synergistic induction of programmed cell death and inhibition of sternness

BIOCHEMICAL PHARMACOLOGY

IF5.6

2018-10-0119

PREAI